Stephen Wargacki - Chief Science Officer at Aquestive Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Science Officer
Stock Symbol
AQST on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen Wargacki since 12/25/2023

Holdings reported by Stephen Wargacki for Aquestive Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 268K $1.31M $4.88 May 10, 2024 Direct
Performance Stock Units 67.5K Aug 9, 2023 Direct Common Stock
Non-Qualified Stock Option (right to buy) 56.3K Mar 7, 2024 Direct Common Stock

Transactions reported by Stephen Wargacki for Aquestive Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.